Hormonersatztherapie bei prämaturer Ovarialinsuffizienz: Rationale, Indikation und Dauer
BackgroundPremature ovarian insufficiency (POI) involving a loss of estrogen production is a life-determining situation for affected women, leading to infertility and chronic sequelae for women’s health. This requires long-term strategies for hormone replacement over years or even decades.Objectives...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
30. Juni 2017
|
| In: |
Der Gynäkologe
Year: 2017, Jahrgang: 50, Heft: 8, Pages: 606-611 |
| ISSN: | 1433-0393 |
| DOI: | 10.1007/s00129-017-4095-2 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00129-017-4095-2 Verlag, Volltext: https://link.springer.com/article/10.1007/s00129-017-4095-2 
|
| Verfasserangaben: | T. Strowitzki, Abt. für Gyn. Endokrinologie und Fertilitätsstörungen, UniversitätsklinikumHeidelberg, Heidelberg, Deutschland |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576164888 | ||
| 003 | DE-627 | ||
| 005 | 20220814155332.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180607s2017 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00129-017-4095-2 |2 doi | |
| 035 | |a (DE-627)1576164888 | ||
| 035 | |a (DE-576)506164888 | ||
| 035 | |a (DE-599)BSZ506164888 | ||
| 035 | |a (OCoLC)1341011249 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Strowitzki, Thomas |d 1959- |e VerfasserIn |0 (DE-588)118055917 |0 (DE-627)079216099 |0 (DE-576)17102141X |4 aut | |
| 245 | 1 | 0 | |a Hormonersatztherapie bei prämaturer Ovarialinsuffizienz |b Rationale, Indikation und Dauer |c T. Strowitzki, Abt. für Gyn. Endokrinologie und Fertilitätsstörungen, UniversitätsklinikumHeidelberg, Heidelberg, Deutschland |
| 264 | 1 | |c 30. Juni 2017 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.08.2020 | ||
| 520 | |a BackgroundPremature ovarian insufficiency (POI) involving a loss of estrogen production is a life-determining situation for affected women, leading to infertility and chronic sequelae for women’s health. This requires long-term strategies for hormone replacement over years or even decades.ObjectivesThis review pays special attention to the risks, benefits, administration and treatment duration of hormonal replacement, all of which differ substantially from the situation in natural menopause.Results and discussionThere is wide consensus that hormone replacement therapy is indicated in women with POI if potential contraindications are excluded. The transdermal cyclic approach is considered the first choice. In women requiring definitive contraception, estrogen replacement can be successfully performed using hormonal oral contraceptives. Replacement therapy should be continued at least until the age of natural menopause, i.e., early 50s. Thereafter, hormone therapy follows the standard recommendations for postmenopausal women suffering from climacteric symptoms. | ||
| 773 | 0 | 8 | |i Enthalten in |t Der Gynäkologe |d Berlin : Springer, 1996 |g 50(2017), 8, Seite 606-611 |h Online-Ressource |w (DE-627)253723744 |w (DE-600)1459161-3 |w (DE-576)07237294X |x 1433-0393 |7 nnas |a Hormonersatztherapie bei prämaturer Ovarialinsuffizienz Rationale, Indikation und Dauer |
| 773 | 1 | 8 | |g volume:50 |g year:2017 |g number:8 |g pages:606-611 |g extent:6 |a Hormonersatztherapie bei prämaturer Ovarialinsuffizienz Rationale, Indikation und Dauer |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00129-017-4095-2 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00129-017-4095-2 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180607 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 118055917 |a Strowitzki, Thomas |m 118055917:Strowitzki, Thomas |d 910000 |d 910400 |e 910000PS118055917 |e 910400PS118055917 |k 0/910000/ |k 1/910000/910400/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1576164888 |e 3012082425 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["ger"],"title":[{"title_sort":"Hormonersatztherapie bei prämaturer Ovarialinsuffizienz","subtitle":"Rationale, Indikation und Dauer","title":"Hormonersatztherapie bei prämaturer Ovarialinsuffizienz"}],"recId":"1576164888","note":["Gesehen am 21.08.2020"],"physDesc":[{"extent":"6 S."}],"person":[{"roleDisplay":"VerfasserIn","role":"aut","given":"Thomas","family":"Strowitzki","display":"Strowitzki, Thomas"}],"name":{"displayForm":["T. Strowitzki, Abt. für Gyn. Endokrinologie und Fertilitätsstörungen, UniversitätsklinikumHeidelberg, Heidelberg, Deutschland"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"30. Juni 2017"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"id":{"zdb":["1459161-3"],"eki":["253723744"],"issn":["1433-0393"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"[1996?-2022]","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Hormonersatztherapie bei prämaturer Ovarialinsuffizienz Rationale, Indikation und DauerDer Gynäkologe","recId":"253723744","note":["Gesehen am 28.06.2022"],"pubHistory":["Volume 29, issue 6 (September 1996) [?]-volume 55, issue 5 (May 2022)"],"part":{"text":"50(2017), 8, Seite 606-611","issue":"8","pages":"606-611","year":"2017","volume":"50","extent":"6"},"language":["ger"],"title":[{"title":"Der Gynäkologe","title_sort":"Gynäkologe","subtitle":"Fortbildungsorgan der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe"}]}],"id":{"eki":["1576164888"],"doi":["10.1007/s00129-017-4095-2"]}} | ||
| SRT | |a STROWITZKIHORMONERSA3020 | ||